ACADIA Pharmaceuticals
ACAD
#3224
Rank
โ‚ฌ3.88 B
Marketcap
22,97ย โ‚ฌ
Share price
-2.48%
Change (1 day)
29.38%
Change (1 year)

Revenue for ACADIA Pharmaceuticals (ACAD)

Revenue in 2025 (TTM): โ‚ฌ0.93 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.89 Billion. In 2024 the company made a revenue of โ‚ฌ0.92 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ0.65 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ACADIA Pharmaceuticals from 2003 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.93 B1.82%
2024 โ‚ฌ0.92 B40.06%
2023 โ‚ฌ0.65 B36.28%
2022 โ‚ฌ0.48 B12.79%
2021 โ‚ฌ0.42 B19.03%
2020 โ‚ฌ0.35 B18.66%
2019 โ‚ฌ0.30 B54.72%
2018 โ‚ฌ0.19 B87.94%
2017 โ‚ฌ0.10 B531.78%
2016 โ‚ฌ16.47 M29433.7%
2015 โ‚ฌ0.05 M-43.92%
2014 โ‚ฌ0.09 M-88%
2013 โ‚ฌ0.82 M-77.65%
2012 โ‚ฌ3.7 M133.07%
2011 โ‚ฌ1.59 M-94.98%
2010 โ‚ฌ31.67 M609.36%
2009 โ‚ฌ4.46 M292.64%
2008 โ‚ฌ1.13 M-78.02%
2007 โ‚ฌ5.17 M-16.06%
2006 โ‚ฌ6.16 M-33.35%
2005 โ‚ฌ9.24 M172.49%
2004 โ‚ฌ3.39 M-45.35%
2003 โ‚ฌ6.21 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Vanda Pharmaceuticals
VNDA
โ‚ฌ0.18 B-79.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ53.90 B 5,896.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ51.01 B 5,574.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ79.10 B 8,700.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ41.23 B 4,487.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
โ‚ฌ75.71 M-91.58%๐Ÿ‡บ๐Ÿ‡ธ USA